Simulations Plus
Engineering Software · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
PO Box 12317, Durham, North Carolina, 27...Phone Number
(661) 723-7723Website
www.simulations-plus.comRevenue
$82.1 MillionStock Symbol
SLPIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
5
2
2
2
2
About Simulations Plus
Simulations Plus is a software and consulting company that specializes in providing modeling and simulation solutions for the pharmaceutical and biotechnology industries. The company develops advanced software tools that help drug developers predict how medications will behave in the human body, enabling more efficient drug discovery and development processes. Their solutions support various aspects of pharmaceutical research, including absorption, distribution, metabolism, and excretion modeling, as well as population pharmacokinetics and clinical trial simulations. Simulations Plus serves a global client base of pharmaceutical companies, biotechnology firms, academic institutions, and regulatory agencies, helping them make more informed decisions throughout the drug development lifecycle. The company is recognized for its innovative approach to computational modeling and its commitment to advancing pharmaceutical science through technology.If you need current, specific information abRead more
Simulations Plus Org Chart
SR
Senior Director Business Development
AP
Senior Director, Business Development
KH
Inside Sales Director
AM
Director, Business Development
HS
Director, Business Development
JH
Director, Business
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Simulations Plus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Simulations Plus launches new products
Earning: See what the market has to say on Simulations Plus recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Simulations Plus
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Simulations Plus had a recent Job posting/layoffs
Simulations Plus, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Simulations Plus has new funding data
Check if Simulations Plus has recently received funding, and reach out quickly before it becomes old news!
Check out if Simulations Plus is spiking on competitors!
Recommended Actions
Find VP level buyers at Simulations Plus
Find 3 more new buyers
Compare Similar Companies to Simulations Plus
Compare insights from companies similar to Simulations Plus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Simulations Plus
$82.1M
201-500
Public
$5.8M
1996
JoAnne SchaberickFounder & CEO & Chief Awesomeness Officer
$46.2M
51-200
Private
-
1991
Md
Matheus de OliveiraPresident, Operationsnmagma Foundry Technologies, Inc
Company Profile Activity
Activity Insights
Simulations Plus is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Simulations Plus is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Simulations Plus.
Simulations Plus financials insights
Gather financial insights about Simulations Plus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1997
Stock Offering
$5.8M
Simulations Plus Tech Stack
A closer look at the technologies used by Simulations Plus
See more technologies
Most Recent Scoops
Person-Based
Compliance, Pharmaceuticals, Regulations
Person-Based
Earnings, Financial Reporting, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Earnings, Finance, Mergers
Simulations Plus News & Media
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
SAN DIEGO, July 6, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. On April 3, 2025, Simulations Plus reported...SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm
SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law FirmAltaris's $375m take-private, Sixth Street's Chronograph deal lead software-heavy day
Altaris takes Simulations Plus private for $375m and Sixth Street backs analytics firm Chronograph, as software, data, and healthcare deals lead the day.BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
BALA CYNWYD, Pa., June 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Simulations Plus
Sign Up For FreeTo access detailed company insights
Simulations Plus is a software and consulting company that specializes in providing modeling and simulation solutions for the pharmaceutical and biotechnology industries. The company develops advanced software tools that help drug developers predict how medications will behave in the human body, enabling more efficient drug discovery and developmen... Read More
